Literature DB >> 19059162

Salvage of nonischemic control lung from injury by unilateral ischemic lung with apocynin, a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, in isolated perfused rat lung.

Chenting Zhu1, Aishan Bilali, Gabriela S Georgieva, Shunichi Kurata, Chieko Mitaka, Takasuke Imai.   

Abstract

Ischemia reperfusion (I/R) injury of the lung affects the function of the nonischemic lung. Our objective is to determine how apocynin, which is a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, protects the nonischemic control right lung (RL) from injury by the unilateral ischemic left lung (LL). In isolated ventilated (by air containing 5% CO(2)) rat lungs, in which differential perfusion of the RL or LL was feasible, the LL was selectively made ischemic (60 min) and reperfused (30 min) in a nonrecirculating or recirculating manner with buffer (Krebs-Henseleit) solution, or in a recirculating manner with buffer that contained apocynin (10 mmol/L) or apocynin + TACEI (tumor necrosis factor)-alpha converting enzyme inhibitor; 10 microg/mL) (each group: n = 12) or with buffer that contained SOD (superoxide dismutase, 3000 U before ischemia and at reperfusion) or SOD + TACEI (each group: n = 5). The permeability of pulmonary endothelium/epithelium (wet/dry ratio and protein content of bronchoalveolar lavage fluid of each lung), perfusion pressure, and cytokine messenger RNA (mRNA) expression was increased not only in the LL (compared with nonischemic control RL, P < 0.01 with paired-samples T) but also in the RL in recirculating groups (compared with RL in the nonrecirculating group). Apocynin + TACEI as well as SOD + TACEI prevented those permeability increases in the RL by the ischemic LL. However, apocynin with or without TACEI as well as SOD with or without TACEI could only partially ameliorate I/R injury in the LL (P < 0.01 by 1-way analysis of variance (ANOVA)). TNF-alpha and possibly reactive oxygen species produced and released from the ischemic lung may synergistically induce control RL (remote organ) damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059162     DOI: 10.1016/j.trsl.2008.10.008

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  6 in total

1.  NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.

Authors:  Ashish K Sharma; Damien J LaPar; Matthew L Stone; Yunge Zhao; Christopher K Mehta; Irving L Kron; Victor E Laubach
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

2.  Apocynin attenuates ventilator-induced lung injury in an isolated and perfused rat lung model.

Authors:  Chi-Huei Chiang; Chiao-Hui Chuang; Shiou-Ling Liu; Tzong-Shyuan Lee; Yu Ru Kou; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-05-27       Impact factor: 17.440

3.  A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.

Authors:  Intae Lee; Chandra Dodia; Shampa Chatterjee; John Zagorski; Clementina Mesaros; Ian A Blair; Sheldon I Feinstein; Mahendra Jain; Aron B Fisher
Journal:  J Pharmacol Exp Ther       Date:  2013-03-08       Impact factor: 4.030

4.  NADPH oxidase mediates synergistic effects of IL-17 and TNF-α on CXCL1 expression by epithelial cells after lung ischemia-reperfusion.

Authors:  Ashish K Sharma; Daniel P Mulloy; Lamvy T Le; Victor E Laubach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-01       Impact factor: 5.464

Review 5.  Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.

Authors:  Meng Xiang; Janet Fan; Jie Fan
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

6.  Does methylene blue attenuate inflammation in nonischemic lungs after lung transplantation?

Authors:  Marcus da Matta Abreu; Francine Maria de Almeida; Kelli Borges Dos Santos; Emílio Augusto Campos Pereira de Assis; Rafael Kenji Fonseca Hamada; Fabio Biscegli Jatene; Paulo Manuel Pêgo-Fernandes; Rogerio Pazetti
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.